AMINO-ACIDS OF THE 3RD TRANSMEMBRANE DOMAIN OF THE AT(1A) ANGIOTENSIN-II RECEPTOR ARE INVOLVED IN THE DIFFERENTIAL RECOGNITION OF PEPTIDE AND NONPEPTIDE LIGANDS

被引:44
作者
GROBLEWSKI, T
MAIGRET, B
NOUET, S
LARGUIER, R
LOMBARD, C
BONNAFOUS, JC
MARIE, J
机构
[1] CCIPE,INSERM,U401,F-34094 MONTPELLIER 05,FRANCE
[2] UNIV NANCY 1,CHIM THEOR LAB,F-54506 VANDOEUVRE NANCY,FRANCE
关键词
D O I
10.1006/bbrc.1995.1483
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The differential role of amino acids of the third transmembrane domain on peptide and nonpeptide recognition by the AT(1) angiotensin II receptor has been evidenced. The mutation of Ser(105) into alanine completely abolished peptide agonist and antagonist binding, while the binding of nonpeptide ligands, including the original radioligands [H-3] LF 7-0156 and [H-3] LF 8-0129, was more moderately affected. Reverse pharmacological changes, i.e., unchanged affinities for peptide agonists or antagonists and drastically reduced affinities for nonpeptide antagonists,were observed upon alanine replacement of Asn(111). These results confirm that the binding sites for peptide and nonpeptide molecules are not totally overlapping and delineate new amino acids as candidates for the selective receptor interaction with the two categories of ligands. Their integration in topographical studies is discussed. (C) 1995 Academic Press, Inc.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 39 条
  • [1] A SINGLE AMINO-ACID OF THE CHOLECYSTOKININ-B GASTRIN RECEPTOR DETERMINES SPECIFICITY FOR NONPEPTIDE ANTAGONISTS
    BEINBORN, M
    LEE, YM
    MCBRIDE, EW
    QUINN, SM
    KOPIN, AS
    [J]. NATURE, 1993, 362 (6418) : 348 - 350
  • [2] BERGSMA DJ, 1993, MOL PHARMACOL, V44, P277
  • [3] BONNAFOUS JC, 1988, BIOCHEM J, V253, P765
  • [4] CHANG RSL, 1990, MOL PHARMACOL, V37, P347
  • [5] CHARACTERIZATION OF [H-3] LOSARTAN RECEPTORS IN ISOLATED RAT GLOMERULI
    CHANSEL, D
    VANDERMEERSCH, S
    PHAM, P
    ARDAILLOU, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 247 (02): : 193 - 198
  • [6] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [7] IDENTIFICATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES
    CHIU, AT
    HERBLIN, WF
    MCCALL, DE
    ARDECKY, RJ
    CARINI, DJ
    DUNCIA, JV
    PEASE, LJ
    WONG, PC
    WEXLER, RR
    JOHNSON, AL
    TIMMERMANS, PBMWM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) : 196 - 203
  • [8] DEGLYCOSYLATION AND FRAGMENTATION OF PURIFIED RAT-LIVER ANGIOTENSIN-II RECEPTOR - APPLICATION TO THE MAPPING OF HORMONE-BINDING DOMAINS
    DESARNAUD, F
    MARIE, J
    LOMBARD, C
    LARGUIER, R
    SEYER, R
    LORCA, T
    JARD, S
    BONNAFOUS, JC
    [J]. BIOCHEMICAL JOURNAL, 1993, 289 : 289 - 297
  • [9] DODEY P, 1993, Patent No. 564356
  • [10] REPLACEMENT OF INSULIN-RECEPTOR TYROSINE RESIDUES 1162 AND 1163 COMPROMISES INSULIN-STIMULATED KINASE-ACTIVITY AND UPTAKE OF 2-DEOXYGLUCOSE
    ELLIS, L
    CLAUSER, E
    MORGAN, DO
    EDERY, M
    ROTH, RA
    RUTTER, WJ
    [J]. CELL, 1986, 45 (05) : 721 - 732